Tag: Hatch-Waxman Act

How Generic Drugs Saved the U.S. Healthcare System $3.4 Trillion

by Arnold Kendrick

Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.

FDA Generic Drug Approval: How the ANDA Process Works

by Lillian Everhart

Explore how the FDA approves generic drugs via the ANDA process, ensuring safety and savings. Learn about bioequivalence standards, GDUFA timelines, and the impact of the Hatch-Waxman Act on your medication.

Recent-posts

Biologic Patent Protection: When Biosimilars Can Enter the Market

Aug, 12 2026

Deficiency Letters in Generic Drug Applications: Common FDA Findings and How to Avoid Them

Jan, 16 2026

Alcohol's Impact on Inflammation: What You Need to Know

Mar, 19 2025

West Virginia's Clay County Prepares for New Boost in Tourism with Rail Bikes on Historic Railroad

Aug, 18 2024

Debate on Banning Weight-Loss Drugs Alli and Xenical Intensifies Amid Health Concerns

Mar, 22 2024